Tod Smeal
Chief Tech/Sci/R&D Officer presso CARDIFF ONCOLOGY, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 07/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Tod Smeal
| Società | Posizione | Inizio |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 11/01/2022 |
Precedenti posizioni note di Tod Smeal
| Società | Posizione | Fine |
|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2015 |
Formazione di Tod Smeal
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
- Borsa valori
- Insiders
- Tod Smeal
